ArticleThe oncologist2023

Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma.

Alexander Chehrazi-Raffle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.